On May 1, 2022, Fochon Biosciences, Ltd. officially started operations.
Fochon Biosciences was jointly established by the original R&D team of Fochon Pharmaceuticals and Fosun Pharma again. Fochon Biosciences is headquartered in Liangjiang New Area, Chongqing, and has international presence in Shanghai, Beijing, and San Francisco. We efficiently promote our R&D programs by leveraging global resources.
We are focusing on the development of targeted therapies, especially the next-generation targeted therapies. Using artificial intelligence drug design (AIDD) and structural-based drug design (SBDD) technologies, we are committed to developing Best-In-Class small molecule targeted innovative drugs.